Clinical efficacy of dirithromycin in patients with bacteremic pneumonia
Authors:
- Gregory D. SidesGSGregory D. Sides
- Paul M. ConfortiPCPaul M. Conforti
- Maria G. SmietanaMSMaria G. Smietana
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (6) , 1128-1138
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Dirithromycin increases ethinyl estradiol clearance without allowing ovulationObstetrics & Gynecology, 1995
- THE INFLUENCE OF DIRITHROMYCIN ON THE PHARMACOKINETICS OF CYCLOSPORINE IN HEALTHY SUBJECTS AND IN RENAL TRANSPLANT PATIENTSAmerican Journal of Therapeutics, 1995
- Steady‐State Pharmacokinetics of Theophylline in COPD Patients Treated With DirithromycinThe Journal of Clinical Pharmacology, 1993
- Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human liversAntimicrobial Agents and Chemotherapy, 1993
- From the Food and Drug AdministrationJAMA, 1992
- Pharmacokinetic Drug Interactions of MacrolidesClinical Pharmacokinetics, 1992
- Bacteraemic pneumococcal pneumonia: A continuously evolving diseaseJournal of Infection, 1992
- Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.Thorax, 1991
- Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycinAntimicrobial Agents and Chemotherapy, 1991
- Changes in the Steady‐State Pharmacokinetics of Theophylline During Treatment with DirithromycinThe Journal of Clinical Pharmacology, 1990